Two actions are better than one: Avoiding self-inhibition of serotonergic neurones enhances the effects of serotonin uptake inhibitors

International Clinical Psychopharmacology

Volumn 11, Issue SUPPL. 4, 1996, Pages 1-8

  Romero, L ^a   Bel, N ^a   Casanovas, J M ^a   Artigas, F ^a  

^a INST D INVESTIGACIONS B   (Spain)

Author keywords

5 HT transporter; 5 HT(1A) receptors; 5 Hydroxytryptamine (serotonin); Antidepressants; Dorsal raphe nucleus; Microdialysis; SSRIs (selective serotonin reuptake inhibitors); Tricyclic antidepressants

Indexed keywords

CITALOPRAM; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PAROXETINE; PINDOLOL; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TERTATOLOL;

ANIMAL EXPERIMENT; CONFERENCE PAPER; DEPRESSION; FOREBRAIN; INTRAPERITONEAL DRUG ADMINISTRATION; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029801530     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199609004-00001     Document Type: Conference Paper

References (53)

1. Adell A, Artigas F (1991) Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex: an in vivo microdialysis study. Naunyn Schmiedebergs Arch Pharmacol 343:237-244.
2. Anderson IM, Tomenson BM (1994) The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. J Psychopharmacol 8:238-249.
3. 1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram. Naunyn Schmiedebergs Arch Pharmacol 352:157-165.
4. Artigas F (1993) 5-HT and antidepressants: new views from microdialysis studies. Trends Pharmacol Sci 14:262.
5. Artigas F, Pérez V, Alvarez E (1994a) Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 51:248-251.
6. 1A antagonists and terminal 5-HT release: effects of the combined treatment with 5-HT uptake inhibitors [abstract]. Soc Neurosci Abstr 20:1541.
7. Ayuso-Gutiérrez JL, López-Ibor JJ (1971) Tryptophan and a MAOI (nialamide) in the treatment of depression: a double-blind study. Int Pharmacopsychiatry 7:92-97.
8. Azmitia EC, Segal M (1978) An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 179:641-668.
9. Baker GB, Greenshaw AJ (1989) Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system. Cell Mol Neurobiol 9:1-44.
10. Baraban JM, Aghajanian GK (1980) Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19:355-363.
11. Bel N, Artigas F (1992) Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur J Pharmacol 229:101-103.
12. Bel N, Artigas F (1993) Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15:243-245.
13. Bel N, Artigas F (1996a) Reduction of serotonergic function in rat brain by tryptophan depletion: effects in control and fluvoxamine-treated rats. J Neurochem 67:669-676.
14. Bel N, Artigas F (1996b) In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function: microdialysis studies. J Pharmacol Exp Ther (in press).
15. Blier P, Bergeron R (1995) Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 15:217-222.
16. Blier P, de Montigny C (1994) Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15: 220-226.
17. 1 receptor agonists and p-chloroamphetamine. Synapse 5:120-133.
18. Briley M, Moret C (1993) Neurobiological mechanisms involved in antidepressant therapies. Clin Neuropharmacol 16:387-400.
19. Casanovas JM, Artigas F (1996) Differential effects of ipsapirone on 5-HT release in the dorsal and median raphe neuronal pathways. J Neurochem (in press).
20. Danish University Antidepressant Group (1986) Citalopram: clinical effect profile in comparison with clomipramine: a controlled multicenter study. Psychopharmacology 90:131-138.
21. Danish University Antidepressant Group (1990) Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord 19:289-299.
22. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR (1990) Serotonin function and the mechanism of antidepressant action: reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 47:411-418.
23. Ferré S, Cortés R, Artigas F (1994) Dopaminergic regulation of the serotonergic raphe-striatal pathway: microdialysis studies in freely-moving rats. J Neurosci 14:4839-4846
24. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br J Pharmacol 115:1064-1070.
25. Hajos M, Gartside SE, Sharp T (1995) Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine. Naunyn Schmiedebergs Arch Pharmacol 351:624-629.
26. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study. J Neurochem 60:776-779.
27. 1A autoreceptors in the action of selective serotonin reuptake inhibitors. Eur J Pharmacol 260:251-255.
28. 1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. Life Sci 48:1779-1786.
29. Hoyer D, Schoeffter P (1991) 5-HT receptors: subtypes and second messengers. J Recept Res 11:197-214.
30. Hyttel J (1994) Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 9:19-26.
31. Hyttel J, Overo KF, Arnt J (1984) Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram. Psychopharmacology 83:20-27.
32. Imai H, Steindler DA, Kitai ST (1986) The organization of divergent axonal projections from the midbrain raphe nuclei in the rat. J Comp Neurol 243:363-380.
33. B receptor-mediated inhibition of serotonergic neurons. Eur J Pharmacol 143:195-204.
34. Invernizzi R, Carli M, Di Clemente A, Samanin R (1991) Administration of 8-hydroxy-2-(di-n-propylamino)tetralin in raphe nuclei dorsalis and medianus reduces serotonin synthesis in rat brain: differences in potency and regional sensitivity. J Neurochem 56:243-247.
35. Invernizzi R, Belli S, Samanin R (1992) Citalopram's ability to increase the extracellular concentration of serotonin in the dorsal raphe prevents the drug's effect in frontal cortex. Brain Res 584:322-324.
36. 1A receptors. Eur J Pharmacol 260:243-246.
37. Jacobs BL, Azmitia EC (1992) Structure and function of the brain serotonin system. Physiol Rev 72:165-229.
38. 1A receptors in the rat brain. Naunyn Schmiedebergs Arch Pharmacol 347:453-463.
39. Koe BK, Koch SW, Lebel LA, Minor KW, Page MG (1987) Sertraline, a selective inhibitor of serotonin uptake, induces subsensitivity of beta-adrenoceptor system of rat brain. Eur J Pharmacol 141:187-194.
40. Kosofsky BE, Molliver ME (1987) The serotoninergic innervation of cerebral cortex: different classes of axon terminals arise from dorsal and median raphe nuclei. Synapse 1:153-168.
41. Kreiss DS, Lucki I (1995) Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J Pharmacol Exp Ther 274:866-876.
42. 1A agonist alnespirone (S-20499) on 5-HT release in DRN- and MRN-innervated regions of the rat brain [abstract]. Soc Neurosci Abstr 21:1368.
43. Malagié I, Trillat AC, Jacquot C, Gardier A (1996) Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study. Eur J Pharmacol 286:213-217.
44. de Montigny C, Grunberg F, Maya A, Deschenes JP (1981) Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br J Psychiatry 138:252-256.
45. Nelson JC, Mazure CM, Bowers MB, et al. (1991) A preliminary open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry 48:303-307.
46. Peroutka SJ, Snyder SH (1980) Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210:88-90.
47. 0 proteins in dorsal raphe nucleus. Eur J Pharmacol 265:103-106.
48. 1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology (in press).
49. Rudorfer MV, Potter WZ (1989) Antidepressants: a comparative review of the clinical pharmacology and therapeutic use of the 'newer' versus the 'older' drugs. Drugs 37: 713-738.
50. Rutter JJ, Gundlah C, Auerbach SB (1994) Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine. Neurosci Lett 171:183-186.
51. 1 receptor. Eur J Pharmacol 157:173-181.
52. Thomas DR, Nelson DR, Johnson AM (1987) Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor. Psychopharmacologv 93:193-200.
53. Wilde MI, Plosker GL, Benfield P (1993) Fluvoxamine: an updated review of its pharmacology, and therapeutic use in depressive illness. Drugs 46:895-924.